Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial

NCT06191848 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT06191848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06191848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
University of Melbourne
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 19, 2024
Completion date
May 31, 2037
Enrollment
352 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis, obesity, osteoarthritis, knee